Comparison Of Re-Do Transcatheter Aortic Valve Replacement With Valve-In-Valve For Failed Surgical Aortic Bioprostheses: A Multicenter Analysis Of Clinical And Long-Term Outcome

Matthias Raschpichler,Felix Woitek,Tarun Chakravarty,Chetana Singh,Mohammad Kashif,Chinar Patel,Jasminka Stegic,Stephan Haussig,Philipp Kiefer,Norman Mangner,David Holzhey,Axel Linke,Holger Thiele,Michael A. Borger,Raj Makkar

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2018）

引用 0|浏览27

暂无评分

摘要

Valve-in-Valve (ViV) for failed surgical aortic valve replacement (SAVR) is an effective treatment for patients that are not able to undergo re-operation. Limited data exist for transcatheter aortic valve replacement (TAVR) as a redo for patients that have undergone TAVR procedures. Baseline

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要